RDX-022

N/A

Report date: 2022/11/25 17:29:22

NME

Base Information

Drug NameRDX-022

Drug Alias NameRDX-7675RDX-227675RDX-022

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionPotassium binders

TargetsPotassium

Therapy Area/IndicationsHyperkalemia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesArdelyx Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesArdelyx Inc

Active IndicationsN/A

Inactive IndicationsHyperkalemia

ATC CodeN/A